D-0592-2020 Class II Terminated
FDA drug recall D-0592-2020 was initiated by Coast Quality Pharmacy, LLC Dba Anazao Health on Sep 3, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. The recall status is terminated (terminated Dec 1, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Sep 3, 2019
- Termination Date
- Dec 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Morphine Sulfate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
Reason for recall
Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.
Distribution pattern
Nationwide in the U.S.
Code information
All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0592-2020
- openFDA file date
- Nov 17, 2026
- Loaded by RegDataLab
- Nov 18, 2026